← All diseases
Cancer
Glioblastoma
Would you like to receive a message when there is new research about Glioblastoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Glioblastoma. View what Premium costs.
Publications and studies (2291)
- CAR microglia-like anti‑carbonic anhydrase IX releasing anti-programmed cell death ligand-1 antibodies for glioblastoma. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. AEG-1/MTDH: A central regulator of tumor progression, metabolic adaptation, and therapeutic resistance in gliomas. (2026/08/05) ♡
- Artificial intelligence-based diagnostic model for identifying PTPRZ1-MET fusion in a clinically defined secondary glioblastoma cohort. (2026/08/04) ♡
- Retraction: Inhibition of SAPK2/p38 Enhances Sensitivity to mTORC1 Inhibition by Blocking IRES-Mediated Translation Initiation in Glioblastoma. (2026/08/04) ♡
- Neuroimmune treatment of advanced solid tumors: 3-year survival after angiotensin 1-7, pineal indoles, and cannabinoids. (2026/08/04) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. RETRACTED: Safaee et al. Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines. Molecules 2021, 26, 901. (2026/08/04) ♡
- Fractal and Machine Learning Analyses of MALDI-TOF Mass Spectrometry Data in Glioblastoma. (2026/08/04) ♡
- A New Fluorine-18-Fluoroethyltyrosine Positron-Emission-Tomography/Magnetic-Resonance-Based Tumor Resection Plan Improved the Prognosis of Glioblastoma Patients. A Multicenter Validated Study. (2026/08/04) ♡
- Neurocognitive and neuropsychiatric presentation identifies a higher-risk clinical phenotype in IDH-wildtype glioblastoma: A retrospective cohort study. (2026/08/04) ♡
- A pragmatic adaptation of the RANO clinical risk score for IDH-Wildtype glioblastoma in the absence of MGMT promoter methylation testing. (2026/08/04) ♡
- Trametinib-mediated MEK inhibition impairs cancer cell viability and invasion in patient-derived tumor avatars of glioblastoma with extraneural metastases: A proof-of-concept study. (2026/08/04) ♡
- RUVBL1 supports TIP60-associated proteasome adaptation and temozolomide resistance in glioblastoma. (2026/08/04) ♡
- Polyphosphorylcholine-modified liposomes for glioblastoma-targeted siRNA delivery across the blood-brain barrier. (2026/08/03) ♡
- Retraction: Transcriptional Repression of Mad-Max Complex by Human Umbilical Cord Blood Stem Cells Downregulates Extracellular Signal-Regulated Kinase in Glioblastoma. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Improving T-cell engager efficacy in glioblastoma with multi-antigen targeting and novel delivery approaches. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Rethinking glioma-associated senescence: Drivers of heterogeneity and therapeutic resistance. (2026/08/03) ♡
- Multimodal cell death-associated inflammatory niches recruit but spatially constrain GZMB(+) cytotoxic T lymphocytes in glioblastoma. (2026/08/03) ♡
- Multi-molecular saturation-transfer MR fingerprinting for differentiating tumor progression from treatment-related change in post-treatment IDH-wildtype glioblastoma: a feasibility study. (2026/08/03) ♡
- Plasma Extracellular Vesicles from Glioblastoma Patients Affect Phenotype and Activate Receptor Tyrosine Kinases in Glioblastoma Cells. (2026/08/03) ♡
- Macropa-Based 225Ac-Labeled RGD Peptides for Targeted Alpha Therapy. (2026/08/03) ♡
- Biophysical insights into interaction mechanism of cediranib with human serum albumin: In-vitro and in-silico perspectives. (2026/08/03) ♡
- Deep Learning-Based Multimodal Fusion of Whole-Slide Images and RNA Sequencing Identifies Survival-Relevant Glioblastoma Clusters. (2026/08/01) ♡
- Machine learning models decipher environmental pollutant-driven core genes in glioblastoma: Biomarkers for diagnosis, recurrence, and prognosis. (2026/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. More than just numbers: the expanding burden of non-communicable diseases. (2026/08/01) ♡
- Clinicopathological characteristics and prognostic factors of diffuse infiltrating glioma in Morocco: A retrospective single-center institutional experience under the 2021 WHO classification. (2026/08/01) ♡
- Succinylation of TAGLN2 at K40 drives lipid oxidative stress resistance and TMZ chemoresistance via redox reprogramming in Glioblastoma. (2026/08/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Therapeutic Plasma Exchange for Removal of Bevacizumab: A Case Series. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Microbiota-Neuroinflammation Crosstalk in Primary Brain Tumors: Focus on Glioblastoma. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Harnessing Repurposed Drugs to Enhance Temozolomide Efficacy in Glioblastoma. (2026/08/01) ♡
- Monte Carlo simulations of 241Am α-particle energy distribution, LET distribution, and absorbed dose in a cell layer. (2026/08/01) ♡
- Development of an online neutron beam monitoring method for accelerator-based BNCT using an 8-MeV proton-beryllium source. (2026/08/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Solitary neurocysticercosis mimicking tuberculoma and glioblastoma: A diagnostic challenge in a low-resource setting. (2026/07/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Occipital lobe glial and glioneuronal tumors: A systematic review of clinical presentation, surgical management, and outcomes. (2026/07/31) ♡
- Phase I trial and pharmacokinetic study of berubicin (RTA 744) in patients with recurrent or refractory high-grade gliomas. (2026/07/31) ♡
- Novel 2-amino-4-(1H-imidazol)pyridine derivatives as potent brain-penetrant EGFR mutant inhibitors: Design, synthesis, biological evaluation, and molecular modeling study. (2026/07/30) ♡
- Synthesis & biological evaluation of novel sulfonyl hydrazone derivatives. (2026/07/30) ♡
- Precision RNA-based Gene Silencing and Theranostics Delivery Strategies for Glioma: Advances in siRNA and Emerging miRNA Therapeutics. (2026/07/29) ♡
- GOLPH3 depletion in glioblastoma cells promotes anti-tumor effects and neuronal differentiation by affecting mTOR signaling. (2026/07/29) ♡
- A mechanobiology-driven cell-derived ECM bioink for engineering 3D glioblastoma tumor microenvironment models. (2026/07/29) ♡
- Integrating Large-Scale Bulk and Single-Cell RNA Sequencing with Machine Learning: Unveiling the Cytokine Landscape of Glioblastoma and Constructing a Prognostic Feature Model. (2026/07/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immune-angiogenic crosstalk in glioblastoma: Mechanisms and therapeutic opportunities. (2026/07/28) ♡
- Single-cell transcriptome-guided biomimetic magnetothermal hydrogel microspheres for multimodal eradication of residual glioblastoma. (2026/07/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Cerebrospinal fluid cytology as a diagnostic clue in hemorrhagic glioblastoma mimicking hypertensive intracranial hemorrhage. (2026/07/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Glioblastoma as a neuro-immune network disorder: rethinking the tumor microenvironment, neural circuit integration, and therapeutic resistance. (2026/07/27) ♡
- Dendritic Cell Vaccines for Glioblastoma: A Systematic Review and Meta-Analysis Comparing New-Onset and Recurrent Cases. (2026/07/27) ♡
- Phenethyl isothiocyanate mediates autophagy via the AMPK/mTOR signal pathway in human glioblastoma multiforme cells. (2026/07/26) ♡
- Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth. (2026/07/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MEOX2: a homeobox transcription factor with multifaceted biological functions and broad disease associations. (2026/07/23) ♡
- Prediction of MGMT promoter methylation in glioblastoma and grade 4 astrocytoma using fluid-suppressed chemical exchange saturation transfer MRI and machine learning-based segmentation. (2026/07/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Glioblastoma stem cells as carriers of tumour memory: a strategy for personalised immunotherapy using tumour-infiltrating lymphocytes. (2026/07/22) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.